Dukes' staging is poorly understood by doctors managing colorectal cancer
Coll, A.R.
Annals of the Royal College of Surgeons of England 85(6): 444
2003
ISSN/ISBN: 0035-8843 PMID: 14705244 Document Number: 561808
Document emailed within 1 workday
Related Documents
Rahman, M.R.; Sheikh, S.H.; Lima, I.J.; Islam, M.R.; Faisal, M.; Islam, M.S.; Faruk, M.O.; Jalal, M.T. 2016: Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging Mymensingh Medical Journal: Mmj 25(1): 61-65Makrilia, N.; Indeck, B.; Syrigos, K.; Saif, M.W. 2009: Depression and pancreatic cancer: a poorly understood link Jop: Journal of the Pancreas 10(1): 69-76
Katoh, H.; Yamashita, K.; Kokuba, Y.; Satoh, T.; Ozawa, H.; Hatate, K.; Ihara, A.; Nakamura, T.; Onozato, W.; Watanabe, M. 2008: Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer Anticancer Research 28(3b): 1933-1941
Pelletier, M.; Ricard, C. 2011: Systemic scleroderma. a poorly understood illness Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 8(6): 38-41
Zitman, F.G. 1988: Neuroleptics in anxiety, depression and poorly understood physical symptoms Nederlands Tijdschrift Voor Geneeskunde 132(30): 1380-1383
Hellara, O.; Hammami, A.; Ben Chaabène, N.; Aloui, S.; Melki, W.; Loghmari, H.; Ben Mansour, W.; Safer, L.; Zakhama, A.; Noomen, F.; Bdioui, F.; Saffar, H. 2013: Nephrogenic ascites: a poorly understood syndrome: a case report La Tunisie Medicale 91(11): 671-673
Ishida, H.; Takeuchi, I.; Ohsawa, T.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Suzuki, T.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2002: Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2267-2270
Ishida, H.; Yamada, H.; Shirakawa, K.; Nakada, H.; Ohsawa, T.; Takeuchi, I.; Okada, N.; Yokoyama, M.; Inokuma, S.; Suzuki, T.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Itoyama, S.; Mori, T.; Matsumoto, Y.; Miura, T. 2003: Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1621-1626
Azulay, J.P. 2006: The diagnosis of chronic axonal polyneuropathy: the poorly understood chronic polyradiculoneuritides Revue Neurologique (Paris) 162(12): 1292-1295
Johansson, C.; Holmström, B. 1994: A working group on colorectal cancer. no new system for staging is necessary Lakartidningen 91(34): 2956-2958
Midiri, G.; Giovagnoli, M.R.; Tesoriere, A.; Giarnieri, E.; Covotta, L.; Bertolotti, A.; Vecchione, A.; Di Paola, M. 1998: Is it possible to consider intranuclear DNA imaging analysis as a new parameter in the staging of colorectal cancer? Il Giornale di Chirurgia 19(1-2): 9-12
Berg, D. 1998: Managing the side effects of chemotherapy for colorectal cancer Seminars in Oncology 25(5 Suppl 11: 53-59
Davis, N.C.; Newland, R.C. 1983: The reporting of colorectal cancer: the Australian Clinico-pathological Staging (ACPS) System Medical Journal of Australia 1(6): 282
Grothey, A. 2006: Recognizing and managing toxicities of molecular targeted therapies for colorectal cancer Oncology 20(14 Suppl 10: 21-28
Adell, G.; Boeryd, B.; Frånlund, B.; Sjödahl, R.; Håkansson, L. 1996: Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study European Journal of Surgery 162(8): 637-642
Ribal, M.J.; Mengual, L.; Marín, M.; Algaba, F.; Ars, E.; Fernández, P.L.; Oliva, R.; Villavicencio, H.; Alcaraz, A. 2006: Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging Anticancer Research 26(1a): 411-419
Kodaira, S.; Abe, O.; Teramoto, R.; Kotake, K.; Ikoma, M.; Ii, S.; Ogihara, H.; Shimazu, H.; Katsumata, T.; Takada, Y.; Miyata, J. 1981: Staging and prognosis in colorectal neoplasms Nihon Rinsho. Japanese Journal of Clinical Medicine 39(5): 2117-2122
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Chamadol, N.; Ninpiethoon, T.; Bhudhisawasd, V.; Pairojkul, C. 2005: The role of CT scan in preoperative staging of colorectal carcinoma Journal of the Medical Association of Thailand 88(12): 1847-1853
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954